$MRK
AI AnalysisGenerated on May 11, 2026
AI Score
Hold$MRK
Merck & Co. Inc.
$MRKNYSEHealthcareMega-Cap
Merck is a global pharmaceutical company with leading positions in oncology (Keytruda), vaccines, and animal health.
Market Cap
$280.0B
Revenue (TTM)
$64.2B
+7.0%
Net Income (TTM)
$14.5B
+12.0%
EPS (TTM)
$5.72
P/E Ratio
18.0
Dividend Yield
2.8%
52-Week Range
$99-$134
Beta
0.42
Dimension Scores
Fundamental
75Technical
65Sentiment
72Risk / Reward
76Momentum
62Financial Health
Profitability
80strong
Growth
65moderate
Liquidity
84strong
Solvency
77strong
Efficiency
73strong
Valuation, technical analysis, investment thesis, risk assessment and more for $MRK
Free · No credit card required
Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.